Xenon Pharmaceuticals Inc. (FRA:XP0)
36.60
+0.40 (1.10%)
At close: Dec 19, 2025
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of €2.91 billion as of December 19, 2025. Its market cap has decreased by -5.12% in one year.
Market Cap
2.91B
Enterprise Value
2.44B
Revenue
6.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
€36.60
Market Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from 114.25M to 2.91B, an increase of 2,445.56%. That is a compound annual growth rate of 33.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 2.91B | 0.75% |
| Dec 31, 2024 | 2.89B | -8.90% |
| Dec 29, 2023 | 3.17B | 37.33% |
| Dec 30, 2022 | 2.31B | 59.69% |
| Dec 31, 2021 | 1.45B | 219.04% |
| Dec 31, 2020 | 452.93M | 44.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |